首页> 外国专利> MECHANICALLY ACTIVATED AMORPHOUS GLUCONIC ACID CALCIUM SALT

MECHANICALLY ACTIVATED AMORPHOUS GLUCONIC ACID CALCIUM SALT

机译:机械活化的非晶态葡萄糖酸钙盐

摘要

The invention relates to the creation of mechanically activated amorphous and amorphocrystalline compounds and compositions of a gluconic acid calcium salt, pharmaceutical preparations based thereon, a method for producing same and use for treatment of a wide range of diseases caused by disorders of calcium metabolism in an organism. A concept of the invention, as being claimed and as set forth in the application, consists in that the crystalline gluconic acid calcium salt or its compound with excipients is treated in grinding activator devices either up to the input specific energy value of not greater than 10.4 kJ/g and achieving an amorphocrystalline state or up to the input specific energy value of no less than 10.5 kJ/g and achieving an amorphous state. The obtainable agents are assessed by means of X-ray diffraction, IR, NMR, EPR spectroscopy, mass- or chromato-mass-spectrometry, and a differential thermal analysis. The mechanically activated amorphous and amorphocrystalline compounds and compositions are used as an active principle for preparing pharmaceutical preparations used for therapeutic, therapeutic-preventive and hygienic purposes. The pharmaceutical preparations comprising a therapeutically effective amount of active ingredient are used perorally 1-6 times daily, in dosages of 0.2-6 g, a course of at least 1 month. The invention can be used in medical and food industries in the production of biologically active agents, therapeutic-prophylactic means, medicinals and in practical medicine in treatment of acute osseous, dental and other diseases related to disorders of calcium metabolism in the organism.
机译:本发明涉及机械活化的非晶态和非晶态化合物以及葡萄糖酸钙盐的组合物,基于其的药物制剂,其制备方法以及用于治疗由钙代谢异常引起的多种疾病的方法。生物。如本申请所要求保护的和在本申请中阐述的,本发明的概念在于,在研磨活化剂装置中处理结晶葡萄糖酸钙盐或其化合物与赋形剂,直至输入比能值不大于10.4。 kJ / g并达到非晶态或达到不小于10.5 kJ / g的输入比能值并达到非晶态。借助于X射线衍射,IR,NMR,EPR光谱,质谱或色谱质谱以及差示热分析来评估可获得的试剂。机械活化的非晶态和非晶态化合物和组合物用作制备用于治疗,预防和卫生目的的药物制剂的有效成分。包含治疗有效量的活性成分的药物制剂每天口服1-6次,剂量为0.2-6 g,疗程至少1个月。本发明可用于医学和食品工业中的生物活性剂的生产,预防性治疗的手段,药物以及用于治疗急性骨,牙齿和与生物体内钙代谢异常有关的其他疾病的实用药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号